Skip to main content


Stock Market Drop Not Seen Dampening Healthcare Deal Activity

A steeper fall might cause both buyers and sellers to re-think potential deals, but so far that doesn't seem to be the case yet.

Biotech, pharma stocks tumble amid big market sell-off

Vertex Pharmaceuticals, Amgen and Johnson and Johnson were among the big movers in the biotech and pharmaceutical sectors.

Sanofi announces second billion-dollar deal in a week, and it may not be done

A week after unveiling an $11.6-billion deal for Bioverativ, Sanofi said it was spending another $4.8 billion to acquire Belgian biotech firm Ablynx.

5G, Sanofi, Ablynx, Coincheck and Bruno Mars - 5 Things You Must Know Before the Market Opens

U.S. stock futures trade lower, Donald Trump's national security advisers look at building a 5G network, and France's Sanofi buys Belgian biotech Ablynx.

Why 2018 will be better for biotech deals than 2017

Analysts see a year of robust deal action ahead due in part to clarity from a tax standpoint.

Breaking News

Cisco Systems Stock Leaps On Q4 Earnings Beat, 2023 Sales Outlook As Supply Chain Pressures Ease

"Overall supply constraints began to ease slightly at the back half of the fourth quarter and continuing into the start of the first quarter," said CEO Chuck Robbins.

Apple Preparing For iPhone 14 Launch On September 7 - Report

Bloomberg reported late Wednesday that Apple is eyeing a September 7 launch date for its new iPhone 14 series.

Huge Las Vegas Strip Casino Project Moves Forward

Sin City looks set to welcome another massive resort/casino that's going to compete with industry leaders Caesars and MGM.

Kohl's Stock Slumps After Retailer Guts Full-Year Profit Forecast As Shoppers Feel Inflation Squeeze

“Second quarter results were impacted by a weakening macro environment, high inflation and dampened consumer spending, which especially pressured our middle-income customers," said CEO Michelle Gass.